Non-coding RNA in type 2 diabetes cardio-renal complications and SGLT2 inhibitor response

Type 2 diabetes mellitus (T2DM) is characterized by an uncontrolled increase in blood glucose levels and insulin resistance in cells of various tissues. Vascular complications in T2DM have an inflammatory nature. Drugs with different mechanisms of action have been developed and used to treat T2DM, i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Rykova, Elena Y. (VerfasserIn) , Shmakova, Elena (VerfasserIn) , Damarov, Igor (VerfasserIn) , Merkulova, Tatiana (VerfasserIn) , Kzhyshkowska, Julia (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 19 November 2025
In: International journal of molecular sciences
Year: 2025, Jahrgang: 26, Heft: 22, Pages: 1-53
ISSN:1422-0067
DOI:10.3390/ijms262211198
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.3390/ijms262211198
Verlag, kostenfrei, Volltext: https://www.mdpi.com/1422-0067/26/22/11198
Volltext
Verfasserangaben:Elena Rykova, Elena Shmakova, Igor Damarov, Tatiana Merkulova and Julia Kzhyshkowska

MARC

LEADER 00000naa a2200000 c 4500
001 1950330303
003 DE-627
005 20260127124357.0
007 cr uuu---uuuuu
008 260127s2025 xx |||||o 00| ||eng c
024 7 |a 10.3390/ijms262211198  |2 doi 
035 |a (DE-627)1950330303 
035 |a (DE-599)KXP1950330303 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Rykova, Elena Y.  |e VerfasserIn  |0 (DE-588)1371739684  |0 (DE-627)1931005893  |4 aut 
245 1 0 |a Non-coding RNA in type 2 diabetes cardio-renal complications and SGLT2 inhibitor response  |c Elena Rykova, Elena Shmakova, Igor Damarov, Tatiana Merkulova and Julia Kzhyshkowska 
246 3 0 |a two 
264 1 |c 19 November 2025 
300 |b Illustrationen 
300 |a 53 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Veröffentlicht: 19. November 2025 
500 |a Gesehen am 27.01.2026 
520 |a Type 2 diabetes mellitus (T2DM) is characterized by an uncontrolled increase in blood glucose levels and insulin resistance in cells of various tissues. Vascular complications in T2DM have an inflammatory nature. Drugs with different mechanisms of action have been developed and used to treat T2DM, initially aimed at controlling blood glucose levels. Among them, sodium-glucose cotransporter 2 inhibitors (SGLT2-i) were developed as specific inhibitors of glucose reabsorption in the kidneys, but along with lowering blood glucose levels, they demonstrated multiple (including non-glycemic) positive effects in the treatment of T2DM related to their beneficial effects on the immune system. SGLT2 inhibitors can reduce the risk of diabetic cardiomyopathy (DCM) and chronic kidney disease (CKD) development in patients with and without diabetes. SGLT2-is improve cardio-renal complications through a number of signaling pathways, including those dependent on the involvement of non-coding RNAs (ncRNAs) and their targets. The best-studied classes of ncRNAs are microRNAs, which are short (less than 200 bases) RNAs (miRNAs), long non-coding RNAs (lncRNAs) (more than 200 bases), and circular RNAs (circRNAs). The regulatory effect of ncRNAs has broad physiological significance, and changes in the ncRNAs’ expression are associated with the pathogenesis of different diseases, including T2DM. RNA-seq allows the construction of networks of interactions of lncRNA/circRNA-miRNA-mRNA called competitive endogenous RNA (ceRNA) networks, to identify clinically significant molecular markers, to improve the mechanistic understanding of pathogenesis, and to contribute to the development of new diagnostics and therapies. Our review summarizes the role of non-coding RNA in the action of SGLT2 inhibitors in cardio-renal complications in T2DM. We focus on methods of detection, genetics, and the effects of non-coding RNA. Specific attention is given to the role of non-coding RNAs in the inflammatory reactions of innate immune cells in relation to the SGLT2 inhibitors. 
650 4 |a cardiac fibroblasts 
650 4 |a cardiomyocytes 
650 4 |a chronic inflammation 
650 4 |a diabetic cardiovascular complications 
650 4 |a diabetic nephropathy 
650 4 |a endothelial cells 
650 4 |a innate immune cells 
650 4 |a macrophages 
650 4 |a mesangial renal cells 
650 4 |a ncRNA genetic variants 
650 4 |a non-coding RNAs (ncRNAs) 
650 4 |a podocytes 
650 4 |a SGLT2 inhibitors 
650 4 |a signaling pathways 
650 4 |a tubular epithelial cells 
650 4 |a type 2 diabetes mellitus 
700 1 |a Shmakova, Elena  |e VerfasserIn  |4 aut 
700 1 |a Damarov, Igor  |e VerfasserIn  |4 aut 
700 1 |a Merkulova, Tatiana  |e VerfasserIn  |4 aut 
700 1 |a Kzhyshkowska, Julia  |d 1967-  |e VerfasserIn  |0 (DE-588)102414271X  |0 (DE-627)719213754  |0 (DE-576)368002233  |4 aut 
773 0 8 |i Enthalten in  |t International journal of molecular sciences  |d Basel : Molecular Diversity Preservation International, 2000  |g 26(2025), 22, Artikel-ID 11198, Seite 1-53  |h Online-Ressource  |w (DE-627)316340715  |w (DE-600)2019364-6  |w (DE-576)281194653  |x 1422-0067  |7 nnas  |a Non-coding RNA in type 2 diabetes cardio-renal complications and SGLT2 inhibitor response 
773 1 8 |g volume:26  |g year:2025  |g number:22  |g elocationid:11198  |g pages:1-53  |g extent:53  |a Non-coding RNA in type 2 diabetes cardio-renal complications and SGLT2 inhibitor response 
856 4 0 |u https://doi.org/10.3390/ijms262211198  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext  |7 0 
856 4 0 |u https://www.mdpi.com/1422-0067/26/22/11198  |x Verlag  |z kostenfrei  |3 Volltext  |7 0 
951 |a AR 
992 |a 20260127 
993 |a Article 
994 |a 2025 
998 |g 102414271X  |a Kzhyshkowska, Julia  |m 102414271X:Kzhyshkowska, Julia  |d 60000  |d 63500  |d 60000  |e 60000PK102414271X  |e 63500PK102414271X  |e 60000PK102414271X  |k 0/60000/  |k 1/60000/63500/  |k 0/60000/  |p 5  |y j 
999 |a KXP-PPN1950330303  |e 4861754259 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"role":"aut","given":"Elena Y.","family":"Rykova","display":"Rykova, Elena Y."},{"family":"Shmakova","given":"Elena","role":"aut","display":"Shmakova, Elena"},{"family":"Damarov","given":"Igor","role":"aut","display":"Damarov, Igor"},{"role":"aut","given":"Tatiana","family":"Merkulova","display":"Merkulova, Tatiana"},{"given":"Julia","role":"aut","family":"Kzhyshkowska","display":"Kzhyshkowska, Julia"}],"relHost":[{"id":{"zdb":["2019364-6"],"issn":["1422-0067","1661-6596"],"eki":["316340715"]},"part":{"text":"26(2025), 22, Artikel-ID 11198, Seite 1-53","extent":"53","issue":"22","pages":"1-53","volume":"26","year":"2025"},"pubHistory":["1.2000 -"],"titleAlt":[{"title":"IJMS"}],"disp":"Non-coding RNA in type 2 diabetes cardio-renal complications and SGLT2 inhibitor responseInternational journal of molecular sciences","recId":"316340715","physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"International journal of molecular sciences","title_sort":"International journal of molecular sciences"}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 17.09.20"],"origin":[{"dateIssuedKey":"2000","dateIssuedDisp":"2000-","publisherPlace":"Basel","publisher":"Molecular Diversity Preservation International"}]}],"origin":[{"dateIssuedDisp":"19 November 2025","dateIssuedKey":"2025"}],"title":[{"title_sort":"Non-coding RNA in type 2 diabetes cardio-renal complications and SGLT2 inhibitor response","title":"Non-coding RNA in type 2 diabetes cardio-renal complications and SGLT2 inhibitor response"}],"note":["Veröffentlicht: 19. November 2025","Gesehen am 27.01.2026"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"recId":"1950330303","physDesc":[{"extent":"53 S.","noteIll":"Illustrationen"}],"name":{"displayForm":["Elena Rykova, Elena Shmakova, Igor Damarov, Tatiana Merkulova and Julia Kzhyshkowska"]},"id":{"eki":["1950330303"],"doi":["10.3390/ijms262211198"]}} 
SRT |a RYKOVAELENNONCODINGR1920